Search clinical trials for: Anticoagulant

Total 6511 results

Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

DOCE Study Interaction Between Direct Oral Anticoagulants and Drug-metabolizing Enzyme Inducers

Atrial Fibrillation | Thromboembolism, Venous

Italy
Chinese University of Hong Kong

Recruiting

DOAC in Chinese Patients With Atrial Fibrillation (DOAC-REAL)

Stroke | Brain Diseases | Atrial Fibrillation | Venous Thromboembolism | Stroke, Acute | Major Adverse Cardiovascular Event | Arterial Thromboembolism

Hong Kong
University Hospital, Strasbourg, France

Recruiting

Comparative Study of the Hemorrhagic Risk in Patients Over 75 Years of Age Taking Enoxaparin (ENOX-VTD-H)

Venous Thromboembolic Disease

France
University Hospital of Ferrara

Recruiting

Management of Anticoagulants and Antithrombotics in Patients With CSDH (THERCA)

Anticoagulant-induced Bleeding | Chronic Subdural Hematoma | Thromboembolic Stroke | Cardiovascular Stroke

Italy
CHU de Reims

Recruiting

RPSA as a Potential Prognostic Biomarker of Pancreatic Cancer (PaCaBioMarkeR)

Pancreatic Ductal Adenocarcinoma (PDAC)

France
Helse Nord-Trøndelag HF
Haukeland University Hospital; Addis Ababa University

Recruiting

The Clinical Influence of Developing a Sustainable Cardiac Surgery Service to Reduce the Burden of Rheumatic Heart Disease in Sub-Saharan Africa (RHD-CaSS)

Rheumatic Heart Disease | Anticoagulant Adverse Reaction

Norway, Ethiopia
Southern Medical University, China
Stomatological Hospital, Southern Medical University; Shenzhen Hospital, Southern...

Recruiting

Effectiveness of Regenerative Endodontics Therapy for Single-rooted Mature Permanent Tooth With Pulp Necrosis

Pulp Necrosis

China
Pfizer
Bristol-Myers Squibb

Active, not recruiting

A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer

Thromboembolism

United States
Prothya Biosolutions

Completed

Study Use of PPSB-SD and VP-VI in Patients With Anticoagulant Therapy and Undergoing Acute CPB Surgery

CPB | Oral Anticoagulant Therapy

Belgium
Methodist Health System

Completed

Medication Use Evaluation (MUE) for Continuous Heparin Infusions in Hospitalized Patients

Unfractionated Heparin

United States
Sanguine Biosciences
Novo Nordisk A/S

Completed

Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes (SAN-08961)

Healthy | Chronic Kidney Diseases | Diabetic Kidney Disease | Diabetes Type 2

United States
Portola Pharmaceuticals

Completed

A Study in Older Subjects to Evaluate the Safety and Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Apixaban

Bleeding

United States
Medical University of Vienna

Completed

Risk of Recurrent Venous Thrombosis: A Validation Study of the Vienna Prediction Model

Venous Thromboembolism

Austria
Sanofi

Active, not recruiting

A Comparison of Extended Versus Conventional Duration of Enoxaparin Prophylaxis (i.e., Preventive Treatment) for Venous Thromboembolism (VTE, i.e., Blood Clots in the Veins) and Bleeding Event Risk in a Population With Acute Medical Illness

Venous Thromboembolism

United States
Ministry of Health, Spain
Sociedad Española de Neumología y Cirugía Torácica

Completed

Air Versus Oxygen for Intermediate-Risk Pulmonary Embolism (AIRE) (AIRE)

Pulmonary Embolism

Spain
Bristol-Myers Squibb
Pfizer

Completed

Evaluation of Safety and Effectiveness on Oral Anticoagulants (RCR-OAC)

Atrial Fibrillation

Japan
Bristol-Myers Squibb

Completed

The Study of How Long Participants Stay in the Hospital After Receiving Apixaban for a Blood Clot in the Lung

Pulmonary Embolism (PE) | Pulmonary Thromboembolism

United Kingdom
Instituto de Investigacion Sanitaria La Fe
Hospital Clinic of Barcelona; Hospital Universitario La Fe; Hospital Universitario... and other collaborators

Completed

Thromboprophylaxis for Patients in ICU With COVID-19

Covid19 | Thrombosis | Anticoagulant Therapy

Spain
Janelle Vaughns

Completed

Prophylactic Use of Enoxaparin in Morbidly Obese Adolescents During Bariatric Surgery

Obesity

United States
University Hospital, Montpellier

Terminated

Glomerular Filtration Rate-Estimating Equations During Use of Direct Oral Anticoagulants in Elderly Patients (REINACO)

Atrial Fibrillation | Chronic Kidney Disease | Elderly Patients

France
University of Texas Southwestern Medical Center

Withdrawn

Biological Effect of Warfarin on Pancreatic Cancer

Pancreatic Cancer

United States
Bayer
Janssen Research & Development, LLC

Completed

Treatment Pattern of NOACs (Non-vitamin K Oral Anticoagulants) in Outpatient Users in Colombian Databases (TREND)

Atrial Fibrillation

Colombia
Hospital Universitario Ramon y Cajal
Hospital Clinic of Barcelona; Hospital del Mar; Hospital Universitario 12 de... and other collaborators

Completed

Gastrointestinal Endoscopy in Patients With Prothrombotic Conditions: THE ENDOHEM REGISTRY

Anticoagulants; Circulating, Hemorrhagic Disorder | Gastrointestinal Endoscopy | Gastrointestinal Bleeding | Cardiovascular Complication

Spain
Hospitalsenheden Vest
Boehringer Ingelheim; Erasmus Medical Center; University of Aarhus; Catharina Ziekenhuis... and other collaborators

Completed

Adherence and Coagulation Assays in Dabigatran-treated Patients With Atrial Fibrillation (ARCADE)

Thrombosis | Atrial Fibrillation | Bleeding | Medication Adherence | Drug Effect | Anticoagulants; Circulating, Hemorrhagic Disorder | Drug Use | Blood Coagulation Disorder | Laboratory Problem | Drug Toxicity | Blood Clot | Blood Coagulation Tests | Drug Intolerance

Denmark
Bristol-Myers Squibb

Completed

A Study of Hospital Healthcare Use and Cost in Patients in the Hospital With a Venous Thromboembolism (VTE) Treated With Apixaban or Warfarin in the US

Venous Thromboembolism (VTE)

United States
Parkview Health
Centers for Medicare and Medicaid Services

Completed

Use of Electronic Personal Health Records to Improve Medication Adherence

Atrial Fibrillation | Medication Adherence

United States
Prince of Wales Hospital, Shatin, Hong Kong

Unknown

Use of Anticoagulant, and Associated Factors of Anticoagulant Refusal Atrial Fibrillation Patients

Atrial Fibrillation

Hong Kong
Fujian Medical University

Unknown

Individualized Administration of Warfarin by Polymorphisms of VKORC1 and CYP2C9 Genes

Heart Valve Prosthesis

China
Institut de Terapia Regenerativa Tissular

Unknown

Clinical Trial to Evaluate the Effect and Safety of MSV in Xerostomy

Xerostomia Due to Radiotherapy

Spain
Institute of Liver and Biliary Sciences, India

Completed

To Compare TEG (Thrombelastography) and Conventional Tests in CKD Patients

End Stage Renal Disease | Coagulopathy
Chinese Academy of Medical Sciences, Fuwai Hospital

Unknown

The Appropriate Anticoagulation Duration for Chronic Obstructive Pulmonary Disease With Pulmonary Thromboembolism

COPD Exacerbation | PTE - Pulmonary Thromboembolism

China
University of Campania "Luigi Vanvitelli"
Federico II University; University of Salerno

Unknown

Validation of International Warfarin Pharmacogenetics Consortium (IWPC) Algorithm in Elderly Patients With Comorbidity (VIALE)

Atrial Fibrillation | Thrombus Due to Heart Valve Prosthesis

Italy
University of Erlangen-Nürnberg Medical School

Completed

Multicenter Analysis of Oral Anticoagulant-associated ICH - Part Two (RETRACE-II)

Anticoagulation Associated (VKA & NOAC) Intracerebral Hemorrhage
Centre Hospitalier Universitaire de Saint Etienne

Completed

Risk of Bleeding and Anticoagulation in Atrial Fibrillation: What Predictive Criterion Used? (PREDIC-AGE)

Atrial Fibrillation | Gerontology

France
McMaster University
Heart and Stroke Foundation of Canada; Toronto General Hospital

Completed

Extended Out-of-hospital Low-molecular-weight Heparin Prophylaxis Against DVT and PE in Patients Undergoing Major Lung Resection

Lung Neoplasms | Venous Thrombosis | Pulmonary Embolism

Canada
National University Hospital, Singapore

Unknown

Study of Genetic Factors Other Than CYP2C9 and VKORC1 That Influence Warfarin Dose Requirements in a South-east Asian Population

Cancer

Singapore
Emory University

Completed

Heparin Management During Cardiopulmonary Bypass in Children

Primary Condition: Heart Defects Requiring Surgery With CPB

United States
University of California, Irvine

Completed

Evaluation of Maternal and Fetal Outcomes in Pregnancies in Women With Prosthetic Heart Valves

Pregnancy | Anticoagulation | Prosthetic Heart Valves

United States
Azienda Ospedaliera San Giovanni Battista
University of Turin, Italy

Completed

Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients

Urogenital Neoplasms | Ovarian Neoplasms | Genital Diseases, Female

Italy
University of Lausanne Hospitals

Completed

Heparin's Influence on ROTEM® Analysis

Coronary Artery Disease

Switzerland
JIANG Qing

Completed

Prophylactic Anticoagulation for Preventing Deep Vein Thrombosis After Total Hip Arthroplasty

Deep Vein Thrombosis

China
Hadassah Medical Organization

Unknown

The Effect of Reduced Dose of Enoxaparin on the Outcomes of Treatment With Enoxaparin

Atrial Fibrillation | Acute Coronary Syndrome | Venous Thromboembolism | Hypercoagulability

Israel
University of Sao Paulo
Fundação de Amparo à Pesquisa do Estado de São Paulo

Unknown

Education Program for Patients Receiving Oral Anticoagulation

Cardiovascular Disease | Blood Coagulation Disorders, Inherited | Atrial Fibrillation | Venous Thromboses

Brazil
Kyowa Hakko Kirin UK, Ltd.

Completed

A Study of KW-3357 in Congenital Antithrombin Deficiency

Congenital Antithrombin Deficiency

France, Germany, Italy, Sweden, United Kingdom
The Cooper Health System

Completed

Effect of Warfarin in the Treatment of Metachromatic Leukodystrophy

Metachromatic Leukodystrophy

United States
Johann Wolfgang Goethe University Hospital

Unknown

Determination of Residual Anticoagulatory Effects of Fondaparinux

Anticoagulant Prophylaxis/Therapy

Germany
Luzerner Kantonsspital

Completed

Epidemiologic Data of Patients in a Teaching Hospital

Kidney Diseases | Obesity

Switzerland
Rigshospitalet, Denmark
H:S Laegeambulance

Completed

Efficacy and Safety of Prehospital Administration of Bivalirudin in STEMI Patients

Acute Myocardial Infarction

Denmark
Azienda Ospedaliera Universitaria Policlinico

Completed

Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants (DACUS)

Deep Vein Thrombosis
University Of Perugia

Completed

Influenza Vaccination and Oral Anticoagulant Therapy

Influenza Vaccines | Anticoagulants

Italy

Search clinical trials for: Anticoagulant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cambodia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations